Position Statements and other Clinical Recommendations
Rheumatoid arthritis: getting the facts straight about methotrexate
Dr Mona Marabani leads an interdisciplinary discussion about why early diagnosis and treatment are crucial for improved health outcomes for people with rheumatoid arthritis, and how good communication and collaborative care can help patients get the most out of methotrexate treatment. For CPD certification, click on the link below.
Biosmilars advice re PBAC flagging of Inflectra and Remicade (Infliximab).
AOA/ARA Position Statement on stem cell therapy.
ARA Position Statement on the introduction of biosimilars for the treatment of rheumatic diseases.
ARA Position Statement on the use of medicinal cannabis for musculoskeletal pain.
Low Dose Once-weekly Methotrexate Information
Notes for prescribers of low dose once weekly methotrexate
Notes on the Management of low dose Methotrexate in Hospitals and other Health Care Facilities
Self-Injecting Methotrexate for the Treatment of Arthritis
Pregnancy Prescribing Information
Prescriber’s information on Medications for Rheumatic Diseases in Pregnancy
Australian Rheumatology Assocation Guide to Telehealth
Clinical Care Standards
Osteoarthritis of the Knee Clinical Care Standard May 2017
Screening for LTBI and its management in inflammatory arthritis patients